Xiidra Approved on January 20, 2017

Posted in Latest News on January 20, 2017.

Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.



More Latest News

Third Quarter Performance Report
June 14, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading


Topical Ocular Pharmaceutical Agents added to Formulary
May 27, 2022

The Board of Optometry has added the following Topical Ocular Pharmaceutical Agents to the formulary… Continue reading